155 results
Page 4 of 8
8-K
EX-99.1
sui7 tisejqj
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-99.1
uki2w5cw5 9gtyvnk0gv
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.3
720hs
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
5f2zso8l19q kofah40d
11 Sep 20
Departure of Directors or Certain Officers
4:17pm
424B3
w5asw6a0afdo
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
xvu0 49n7cd7t1tt9
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
xy98ez1pea08uybc
24 Jun 20
Business combination disclosure
5:11pm
8-K
zmmnkplhnw3rcx6e8to
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
2xd4rlg 574i
24 Jun 20
Business combination disclosure
4:03pm
425
1ukipkaaqd
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.1
wxewpp101j snv
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
6emlc4x4
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
i0vpzcnb mffpb1u5db
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
py2ls
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm